Table 4 Fold changes in gene expression in cells treated with LPS (1 μg/ml) as compared to endogenous expression levels in untreated cells.
Gene symbol | Accession No. | Gene name | Fold change in response to LPS |
|---|---|---|---|
C3 | NM_009778 | Complement component 3 | 3.02 |
Il15 | NM_008357 | Interleukin 15 | 6.39 |
Ltb | NM_008518 | Lymphotoxin B | 4.48 |
Atf1 | NM_007497 | Activating transcription factor 1 | 4.43 |
Bcl10 | NM_009740 | B-cell leukemia/lymphoma 10 | 22.13 |
Cflar | NM_009805 | CASP8 and FADD-like apoptosis regulator | 14.01 |
Edg2 | NM_010336 | Endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 | 6.49 |
Relb | NM_009046 | Avian reticuloendotheliosis viral (v-rel) oncogene related B | 21.38 |
Stat1 | NM_009283 | Signal transducer and activator of transcription 1 | 5.89 |
Cd40 | NM_011611 | Cluster of Differentiation 40 | 112.83 |
Nr2c2 | NM_011630 | Nuclear receptor subfamily 2, group C, member 2 | -4.07 |
Peli1 | NM_030015 | Pellino 1 | 5.48 |